Webster Financial Corporation reported fourth-quarter diluted earnings per share of $1.59, topping the consensus estimate of $1.52 and up from $1.43 a year earlier. This marks the third consecutive quarter of EPS outperformance and reflects disciplined expense management, with noninterest expense growing just 2.1% year-over-year despite revenue expansion.

Total revenue for Q4 reached $731 million, modestly above the $729.5 million forecast and up 3.2% from the prior year as net interest income benefited from repricing of core deposits and loan growth. Net income attributable to common stockholders rose to $248.7 million, a 44.8% increase over Q4 2024’s $171.8 million, driven by higher net interest margin and controlled credit costs.

Webster maintains a conservative capital structure, with a debt-to-equity ratio of 0.078 and a CET1 ratio of 11.9%. Its price-to-earnings ratio stands at 10.5 and price-to-sales at 2.71, while an enterprise-value-to-sales multiple of 2.81 and EV/operating cash flow of 6.92 underscore efficient use of resources. An earnings yield of 9.53% further highlights attractive valuation relative to peers.

Analysts maintain a Buy rating with a $70 price target, citing Webster’s low-cost, stable deposit base—particularly its Health Savings Account franchise—as a driver of margin stability and fee income growth. Credit quality remains resilient, though $1.3 billion in rent-regulated commercial real estate loans warrants monitoring. Strong capital ratios and prudent reserve levels are viewed as adequate buffers against potential sector softness.